Facelift incision offers safe option for some thyroid patients

May 31, 2011

AUGUSTA, Ga. - A facelift incision and robotics can help surgeons safely remove a portion of a diseased thyroid from some patients without the characteristic neck scar.

Georgia Health Sciences University surgeons developed the technique utilizing the remote access capabilities of robots, experience gained from another no-neck-scar approach through the armpit and earlier success removing the largest salivary gland from the lower jaw region.

"It is outpatient, it doesn't require a surgical drain and it has the advantage of no neck scar," said Dr. David Terris, Chairman of the GHSU Department of Otolaryngology-Head and Neck Surgery.

The goal was a no-neck-scar technique that's as safe as conventional thyroidectomy, which involves an incision at the base of the neck to gain immediate access to the thyroid, the surgeons report in The Laryngoscope. Two articles detail experiences developing the technique in human cadavers and using it on 14 patients.

"The overarching principle is customizing the surgery to the patient and their disease as opposed to one size fits all. Our advice to patients and surgeons is to do what works best for you," said the studies' corresponding author Terris, who lays out all options for his patients.

Surgery has been done through a multi-inch neck incision for more than 100 years on the thyroid, the endocrine gland just under the Adam's apple that controls the body's metabolic rate. In the last decade, Terris and others have pioneered minimally invasive approaches that can reduce the incision to less than an inch.

In 2004, Terris and colleagues published another Laryngoscope paper that indicated, at least in pigs, the armpit approach worked for avoiding neck scars altogether. While this approach is used selectively in other countries, reports have surfaced of serious side effects such as damage to the brachial plexus, the main nerve to the arm and hand; blood loss; and perforation of the esophagus. After using it on small number of patients, Terris envisioned a more direct, logical route. That's when he thought about his earlier success at removing the large salivary gland through a facelift incision in the hairline.

The daVinci Surgical System, in which surgeons sitting at a console maneuver through tight spaces and around corners, enables remote access, via the armpit or a facelift incision, Terris said. He makes a small incision in the scalp line, burrows under the skin, then moves under the muscle as he nears the thyroid. A retractor developed by Korean surgeons keeps the skin and muscle out of the way while the long, flexible arms and three- dimensional perspective provided by the robot enables removal of up to half of the two-sided thyroid gland. Patients with known cancers or large thyroids are not candidates for this approach but Terris said advances in robotic technology may soon enable surgeons to reach around to access both sides of the thyroid through a single incision.

He notes the hairline approach takes longer and, primarily because of increased time under anesthesia, costs more than minimally invasive surgeries. He's now done more than 30 cases, but greater patient numbers are needed to increase confidence in the safety and feasibility of the approach, he said.

Unlike minimally invasive approaches that are easier on thin patients, the facelift thyroidectomy is actually easier on heavier patients. A common, transient side effect of this approach is temporary, localized numbness because of surgical contact with the nerve that innervates skin in the region.

Problems with the thyroid gland tend to occur in women in their 30s, 40s and 50s. Growths or goiters can result in a hyperactive thyroid gland and jittery, sweaty patients who can't gain weight. Typically if there is a single growth, the surgeons take out that half of the gland, rule out cancer and that is the end of the problem. If it is cancer, the good news is the thyroid can be completely removed, cure rates are high and the gland's function can be replaced by a single, daily pill, Terris said. Known causes of thyroid cancer include radiation exposure.
-end-
GHSU's Drs. Michael Singer and Melanie Seybt are study co-authors.

Medical College of Georgia at Augusta University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.